Senoptica exits examinership, despite misgivings of co-founder
The Circuit Court today confirmed a scheme of arrangement for biotech start-up Senoptica based on an investment proposal from company creditors, despite misgivings from some of the co-founders, who appeared in court to put their concerns “on the public record”. The company, spun out of TCD in 2018, develops food-sensor technology to monitor the condition of packaged food. The court was told that the company has intellectual property that “everyone agrees is very valuable”. Senoptica went into examinership last year at the instigation of creditors. It was an unusual move that was prompted by a stand-off between management and creditors…
Join today with an Annual membership and get full access to The Currency for just €200 (68c per day) or try monthly membership for just €5 for your first month.
Subscribe
Cancel at any time.
Are you already a member? .
